Despite the existence of current treatments for major depressive disorder (MDD), depression symptoms and burdens often persist, prompting the need for novel therapies, including psychedelic-assisted therapy (PAT), with promising potential for early and durable antidepressant responses. Objectives: This research aims to compare pharmacist opinions regarding logistical and ethical considerations...
Serotonergic psychedelics have shown promise in clinical trials for treating an array of mental health disorders, including depression, anxiety, and post-traumatic stress disorder. Despite these findings, our understanding of how these drugs mechanistically exert their therapeutic effects remains incomplete. While researchers have regularly employed rodent preclinical models to assess such...